CBX-21404

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCBX-21404
Drug Alias NameCBX-21404
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophage migration inhibitory factor inhibitors
TargetsMacrophage migration inhibitory factor
Therapy Area/IndicationsInflammationAutoimmune DiseasesProstatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCiblex
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCiblex
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesProstatic Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A